Clinical Trial Update: Expanded Access Protocol Thymus Transplantation [Phase 4]

View source ↗

Summary

Expanded Access Protocol Thymus Transplantation (Phase 4) has posted results for patients with poor thymic function and immunodeficiency. The sponsor is Sumitom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Athymia
• Immunodeficiency

Snippet

Sponsor: Sumitomo Pharma Switzerland GmbH | Conditions: Poor Thymic Function, Immunodeficiency | Phase 4 | Status: COMPLETED | Results posted: 2025-01-16